Treatment of Obesity in Heart Failure
-
Published:2024-07
Issue:7
Volume:12
Page:1309-1313
-
ISSN:2213-1779
-
Container-title:JACC: Heart Failure
-
language:en
-
Short-container-title:JACC: Heart Failure
Reference19 articles.
1. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;J Am Coll Cardiol,2022
2. A randomized, controlled trial of 3.0 mg of liraglutide in weight management;Pi-Sunyer;N Engl J Med,2015
3. Effects of liraglutide on cardiovascular outcomes in patients with diabetes with or without heart failure;Marso;J Am Coll Cardiol,2020
4. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial;Davies;Lancet,2021
5. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016